A 59-year-old man diagnosed 35 years ago with Crohn's disease that was well controlled
by infliximab, presented to the emergency room with a 4-week history of intermittent
fever. For the past 2 months, he has also been under evaluation for a computerized
tomography (CT)-diagnosed posterior left chest mass eroding into the 11th rib.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Granulomatous infectious diseases associated with tumor necrosis factor antagonists.Clin Infect Dis. 2004; 38: 1261-1265
- Nontuberculous mycobacteria infections and anti-tumor necrosis factor-α therapy.Emerg Infect Dis. 2009; 15: 1556-1561
- Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease.Gastroenterology. 2003; 124: 1774-1785
Article Info
Publication History
Published online: December 11, 2020
Footnotes
Funding: None.
Conflict of Interest: None.
Authorship: All authors had access to the data and a role in writing this manuscript.
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
